These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6976242)

  • 21. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations.
    Bowen B; Hawk JJ; Sibunka S; Hovick S; Weiler JM
    Clin Immunol; 2001 Feb; 98(2):157-63. PubMed ID: 11161971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy.
    Kaplan AP
    J Allergy Clin Immunol; 2010 Nov; 126(5):918-25. PubMed ID: 20889195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hereditary angioedema. A clinical and immunologic contribution based on our 8 clinical cases under long-term treatment with androgens].
    Zimmermann HP; Wüthrich B; Späth P
    Schweiz Med Wochenschr; 1983 Jun; 113(24):876-84. PubMed ID: 6879139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paternal mosaicism and hereditary angioedema in a Taiwanese family.
    Yu TC; Shyur SD; Huang LH; Wen DC; Li JS
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):375-9. PubMed ID: 17941288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current diagnostic possibilities in hereditary angioedema and acquired angioedema].
    Dick W; Cullmann W
    Immun Infekt; 1985 May; 13(3):113-8. PubMed ID: 3924818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel therapies for hereditary angioedema.
    Zuraw BL
    Immunol Allergy Clin North Am; 2006 Nov; 26(4):691-708. PubMed ID: 17085285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodiffusion assay of C1 inhibitor function in serum: prospective analysis in angioedema-urticaria.
    Yelvington M; Prograis LJ; Pizzo CJ; Curd JG
    Am J Clin Pathol; 1983 Sep; 80(3):309-13. PubMed ID: 6410904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary angioedema: a study of three families.
    Pola J; Valdivieso R; Zapata C; Carrillo T; Moneo I; Hinojosa M; Losada E
    Allergol Immunopathol (Madr); 1987; 15(6):375-8. PubMed ID: 3445878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C1 inhibitor functional activities in hereditary angioedema plasma of patients under therapy with attenuated androgens.
    Späth PJ; Wüthrich B; Bütler R
    Dermatologica; 1984; 169(5):301-4. PubMed ID: 6437886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Half-life of C1INH in hereditary angioneurotic oedema (HAE).
    Brackertz D; Isler E; Kueppers F
    Clin Allergy; 1975 Mar; 5(1):89-94. PubMed ID: 1053433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum C1-esterase inhibitor (C1INH) levels in normal adults.
    Ongaro G; Calabrò A; Panunzio MT
    Quad Sclavo Diagn; 1982 Mar; 18(1):104-13. PubMed ID: 6818608
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of C1 inhibitor-Ta. A dysfunctional C1INH with deletion of lysine 251.
    Zahedi R; Aulak KS; Eldering E; Davis AE
    J Biol Chem; 1996 Sep; 271(39):24307-12. PubMed ID: 8798678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1 inhibitor function using contact-phase proteases as target: evaluation of an innovative assay.
    Ghannam A; Sellier P; Defendi F; Favier B; Charignon D; López-Lera A; López-Trascasa M; Ponard D; Drouet C
    Allergy; 2015 Sep; 70(9):1103-11. PubMed ID: 26010015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary angioedema with normal C1-inhibitor activity in women.
    Bork K; Barnstedt SE; Koch P; Traupe H
    Lancet; 2000 Jul; 356(9225):213-7. PubMed ID: 10963200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type II hereditary angioedema: presentation and follow-up of three cases.
    Arias J; Moral A; García MA; Fernández-Rivas M; Abengózar R; Panadero P; Senent C
    Allergol Immunopathol (Madr); 1994; 22(6):244-9. PubMed ID: 7892812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.